VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
May 4, 2018
Document Date
May 3, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Watkins Thomas
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |